Previous Article | Next Article ![]()
Journal of Virology, June 2006, p. 5494-5498, Vol. 80, No. 11
0022-538X/06/$08.00+0 doi:10.1128/JVI.00026-06
Copyright © 2006, American Society for Microbiology. All Rights Reserved.
George T. Shubeita,2,
Kelly E. Coller,1
Joy I. Lee,1
Sarah Haverlock-Moyns,1
Steven P. Gross,2,
and
Gregory A. Smith1,
*
Department of Microbiology-Immunology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois,1 Department of Developmental and Cell Biology, University of California, Irvine, California2
Received 4 January 2006/ Accepted 6 March 2006
|
|
|---|
|
|
|---|
How herpesvirus capsids co-opt dynein has yet to be resolved. Several herpesvirus proteins (UL9, UL34, VP11/12, and VP26) bind to components of the dynein motor complex in yeast two-hybrid or in vitro assays (9, 16, 24). The relevance of these interactions is not immediately clear. The UL34 protein is not incorporated into extracellular virions and therefore cannot be associated with capsids during transport to the nucleus (12, 17). The UL9 protein plays an essential role in virus replication but, similar to UL34, has not been reported as a structural component of virions. The VP11/12 protein is not present on capsids undergoing retrograde transport toward the nucleus and is therefore unlikely to participate in this process (10). In contrast, the VP26 protein is a surface component of the capsid and is thus a candidate to recruit dynein (3, 11).
VP26 was further implicated in the process of capsid transport by assembling capsids with a baculovirus expression system. Capsids assembled in the absence of VP26 show a reduced propensity to cluster around the nucleus after microinjection into cells, compared to capsids assembled in the presence of VP26 (9). However, a mutant of herpes simplex virus type 1 (HSV-1) lacking VP26 is transported to sensory ganglia following inoculation into the mouse cornea (4). This indicates either that VP26 does not participate in retrograde capsid translocation during infection or that VP26 is only partly responsible for this process. To clarify the role of the VP26-dynein interaction in retrograde capsid transport, we provide the first examination of the dynamics of VP26-null capsids in living cells and find that VP26 plays no detectable role in capsid transport. Because this finding strengthens a possible role for the tegument proteins in capsid transport, we made a collection of viruses, each with a deletion of one of the tegument genes. We find that, of the 11 tegument proteins that are not essential for virus propagation in cell culture and could therefore be included in this study, none were required for retrograde axonal transport. These findings are consistent with an essential virus protein, such as the VP1/2 tegument protein, being the mediator of intracellular capsid transport to the nucleus.
|
|
|---|
Dorsal root ganglia explants were isolated from E8-E10 chicken embryos and cultured on poly-DL-ornithine and laminin as previously described (20). Neurons were cultured for 2 to 3 days before being infected.
Construction of recombinant virus strains. PRV-GS443 and PRV-GS847 encode green fluorescent protein (GFP) and monomeric red-fluorescent protein (mRFP1) fused to the UL35 gene product (VP26 capsid protein), respectively, and were previously described (2, 20, 21). PRV-GS962 encodes mRFP1 fused to the N terminus of the UL36 gene product (VP1/2 tegument protein) and is identical to the previously described PRV-GS935, with the coding sequence for mRFP1 in place of that for the latter's GFP (14). PRV-GS962 was made by RecA-dependent homologous recombination by previously described methods (18).
Disruption of UL4, UL14, UL21, UL35, UL41, UL46, UL47, UL48, UL49, and UL51 was accomplished by first inserting a kanamycin marker flanked with Flp recombination target (FRT) sites into the infectious clone by RED-GAM mutagenesis, followed by FLP recombinase-mediated excision of the marker, as previously described (14). The mutations are summarized in Table S1 in the supplemental material. In each case, primers were designed to encode 40 bp of homology flanking the gene targeted for deletion. Each primer also encoded an FRT sequence (underlined sequence in Table S1 in the supplemental material) with one FRT site preceded by a stop codon (shown in bold in Table S1 in the supplemental material). The linear PCR product was recombined into either pGS962 (for deletion of UL35) or pGS443 (for deletion of tegument-encoding genes) by RecA-independent homologous recombination in the Escherichia coli strain EL250. The kanamycin marker was subsequently removed by Flp-mediated recombination at the two FRT sites. The resulting infectious clones carry a stop codon and a single 34-bp FRT site in the target gene and, in all but one case (UL14), a deletion within the target coding sequence. A deletion was not introduced into the UL14 coding sequence, due to the proximity of the UL13 and UL15 genes, which overlap the UL14 coding sequence. Deletions removed the entire coding sequence of the target gene when possible but in some instances were designed to avoid polar effects on neighboring genes (UL4, UL47, UL49, and UL51).
Deletion of either the US3 or UL13 gene was achieved by RecA-dependent homologous recombination with the pGS847 infectious clone. The deletion alleles were made with the following primers: for deletion of UL13, 5'-GGAGGAGGCGTGAGCTAACTGCCGTACGAGGTGG-3' and, for deletion of US3, 5'-CCAACTCGCGCACCATGTAATTGACGTTTGATCCCGTCC-3'. Each primer was paired with a reverse-complement primer and used in a sequential overlap extension PCR to produce the mutant allele, which was subsequently cloned into the pGS284 allelic exchange vector and recombined with pGS847, resulting in pGS950 and pGS1015 (18). The UL13 deletion replaces codons 12 to 278 (of 398 codons total) with a single TAA stop codon, thereby leaving the overlapping UL12 and UL14 genes intact. The US3 deletion replaces codons 2 to 368 (of 390 codons total and relative to the minor US3-coding sequence) with a TAA stop codon.
Fluorescence microscopy. All images were captured with an inverted wide-field Nikon Eclipse TE2000-U (Sutter Instruments, Novato, Calif.) and a Cascade:650 camera (Photometrics; Roper Scientific). The microscope was housed in a box, with the environment kept at 37°C (Life Imaging Services, Reinach, Switzerland). Images were acquired and processed using the Metamorph software package (Molecular Devices, Downington, Pa.).
Living primary neurons from chicken dorsal root ganglia were imaged in sealed chambers with a 60 x 1.4 numeric aperture oil objective as previously described (21). In axons, capsid transport toward the cell body was recorded by time-lapse fluorescence microscopy of mRFP1 or GFP emissions, and the emissions were tracked and analyzed as previously described (21).
|
|
|---|
The coding sequences for the monomeric red-fluorescent protein were inserted into the 5' end of the VP1/2 gene (UL36) by RecA-dependent homologous recombination with the pBecker3 infectious clone, resulting in pGS962 (2, 19). Deletion of the entire VP26-coding sequence from pGS962 resulted in pGS1205. Transfection of pGS962 and pGS1205 into pig kidney epithelial (PK15) cells produced the viruses PRV-GS962 and PRV-GS1205, respectively.
Although a VP26-null strain of HSV-1 has previously been described, the propagation kinetics of a VP26-null alphaherpesvirus have not previously been examined (4). Therefore, the kinetics of virus entry and propagation of PRV-GS962 and PRV-GS1205 were examined by single-step growth analysis in PK15 cells. PRV-GS962 propagation occurred at a rate equivalent to that of our previous reports for the wild-type PRV-Becker (14). Intracellular PFU were detected as early as 2 h postinfection at similar titers for both viruses, indicating that the absence of VP26 did not impact the ability of PRV-GS1205 to reach the nucleus and undergo replication (Fig. 1). We noted that PRV-GS1205 released fewer PFU in the culture media than PRV-962, indicating a role for VP26 in virus egress or capsid/virion stability. In a separate experiment, an approximate twofold decrease in overall burst size was observed with PRV lacking VP26 (PRV-GS962, 6 x 108 PFU/ml; PRV-GS1205, 3 x 108 PFU/ml), similar to that of a previous report for HSV-1 lacking VP26 (4).
![]() View larger version (14K): [in a new window] |
FIG. 1. Single-step growth kinetics of VP26- and VP26-null fluorescent viruses. Virions were harvested from media (dashed lines, open symbols) and PK15 cells (solid lines, filled symbols) at the indicated times. Squares, PRV-GS962; circles, PRV-GS1205.
|
![]() View larger version (83K): [in a new window] |
FIG. 2. VP26-null capsid retrograde axonal transport. Example of virus particle transport resulting from infection of dorsal root sensory neurons with PRV-GS1205 and imaged within the first hour postinfection. A montage of eight frames from a subregion of a time-lapse recording are shown (see movie M1 in the supplemental material for the entire time-lapse recording). Each frame is a 200-ms exposure representing every fourth frame of the original recording (the montage represents a 6.4-s time window). A single VP26-null capsid (mRFP1-VP1/2) complex is shown in the montage. The frames are each 2.7 µm x 15.2 µm.
|
![]() View larger version (21K): [in a new window] |
FIG. 3. Analysis of capsid transport velocities. Histogram of retrograde transport velocities of individual virus particles resulting from infections of dorsal root sensory neurons with PRV-GS962 (a) and PRV-GS1205 (b). The smooth curve in each panel represents the best-fit Gaussian curve for each sample.
|
Infection of cultured dorsal root sensory neurons was performed as described above; however, imaging of axons was performed with 50-ms exposure times (20 frames/s), which was possible due to the brighter fluorescence achieved by fusion of a fluorescent protein to VP26 as opposed to VP1/2. Capsids moving progressively in the retrograde direction were readily observed for each mutant virus, although, as expected, mutant viruses that produced low titers produced fewer observable moving capsids (data not shown). An initial assessment of capsid velocities, which included tracking 30 or more uninterrupted runs of capsid motion from at least 12 recordings each, indicated that transport was not grossly affected by the absence of any of the 11 tegument proteins examined (Table 1).
|
View this table: [in a new window] |
TABLE 1. Retrograde transport of capsids following infection of dorsal root sensory neurons
|
|
|
|---|
VP26 binds the VP5 major capsid protein at a 1:1 ratio on hexons, resulting in 900 copies of VP26 on the capsid surface and making VP26 an attractive candidate as a recruiter of dynein (1, 23, 26). However, reports on the role of VP26 in capsid transport have yielded somewhat contradictory conclusions. Assembly of capsid structures with or without VP26 in insect cells and subsequent microinjection of the particles into mammalian cells support a role for VP26 in the retrograde transport of capsids along microtubules (9). However, a virus with a deletion of the gene encoding VP26, UL35, is competent for retrograde axonal transport in a mouse model of infection (4). We therefore set out to image and track individual VP26-null capsids during retrograde axonal transport in cultured sensory neurons. Although previous studies imaged capsids in living cells by virtue of a GFP-VP26 fusion, imaging VP26-null capsids was made possible by fusing mRFP1 to the capsid-associated tegument protein, VP1/2 (5-7, 14, 20, 21).
The absence of VP26 was found to have no impact on the kinetics of capsid retrograde transport in axons. This finding was unexpected, as the absence of the 900 copies of VP26 results in a significant alteration in capsid surface topology (26). Yet we find that transport of these aberrant capsids proceeds with kinetics that are indistinguishable from those of fully assembled capsids. The simplest explanation is that the VP26 protein plays no role in the retrograde transport of capsids toward the nucleus. This indicates that another capsid protein or capsid-associated protein (i.e., tegument protein) mediates the relevant interaction with dynein. On the capsid surface, the absence of VP26 at pentons exposes the VP5 major capsid protein. Although VP5 coprecipitates with dynein from infected cells, this interaction is likely indirect, as the capsid vertices are binding sites for the tegument, and capsid-tegument interactions persist after virus entry into cells (14, 24, 25). Our findings further demonstrate that VP1/2 association with capsids is independent of VP26, which is consistent with its binding via the vertices. Therefore, VP5 is probably not available for direct interactions with dynein.
We therefore examined the roles of the tegument proteins in retrograde capsid transport. Eleven mutant viruses were made, each lacking a single tegument protein. Two additional mutant viruses, with the gene encoding either the VP1/2 or UL37 tegument protein deleted, were previously made but could not be included in the current study (15). The VP1/2 tegument protein is required for viral propagation and therefore could not be used to infect cells in the absence of the VP1/2 protein. Similarly, propagation of the
UL37 isolate of PRV resulted in titers that were insufficient for the subsequent imaging of capsid transport in our neuronal cultures following infection. Of the remaining 11 tegument-knockout viruses examined, none were notably impaired for retrograde transport. Small variations in the rate of transport were observed among the mutant viruses, but these differences may result from the small number of infected cells from which capsid velocities were analyzed (data not shown). A thorough examination of capsid transport dynamics, similar to that conducted for the VP26-null virus, for all 11 mutant viruses was beyond the scope of this study. However, we expect that the observed variations in transport velocities may not be relevant, as at least one of the mutants with reduced velocity lacked a protein (VP13/14) that is not associated with intracellular capsids after entry into cells and is therefore unlikely to participate in the transport process (10, 14).
Based on the exclusion of the proteins examined in this report from the transport process, a role for the VP1/2 or UL37 tegument proteins in dynein binding and capsid transport is supported. This model is consistent with the finding that both VP1/2 and UL37 remain associated with capsids as they traverse the cytosol to the nucleus (10, 14). We have recently determined that VP1/2, but not UL37, is required for the transport of capsids along microtubules during the egress phase of infection (15). Whether the microtubule-based transport of viral particles following entry and during the egress phase proceeds by a related mechanism is unknown but is of much interest. Although yeast two-hybrid assays have so far failed to identify interactions between dynein and VP1/2 or UL37, we expect that additional genetic manipulations of these viruses will result in the identification of the relevant participants in the microtubule-based transport of herpesvirus capsids (9).
We thank Dmitri Petrov for help in data analysis and Bruce Banfield for helpful discussions of the data.
Supplemental material for this article may be found at http://jvi.asm.org/. ![]()
S.E.A. and G.T.S. contributed equally to this work. ![]()
S.P.G. and G.A.S. are co-senior authors. ![]()
|
|
|---|
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»